Avanos Medical (AVNS) Non-Current Deferred Tax Liability (2014 - 2026)

Avanos Medical (AVNS) has 13 years of Non-Current Deferred Tax Liability data on file, last reported at $5.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $5.6 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (changed 0.0% YoY), and the FY2025 full-year result was $6.1 million, up 10.91% from the prior year.
• Non-Current Deferred Tax Liability declined to $5.6 million in Q1 2026, from $6.1 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $37.0 million in Q3 2022 to a low of $5.5 million in Q4 2024.
• A 5-year average of $19.9 million and a median of $23.6 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability surged 560.71% in 2022 and slumped 76.89% in 2024, its largest moves.
• Tracing AVNS's Non-Current Deferred Tax Liability over 5 years: stood at $25.4 million in 2022, then declined by 6.3% to $23.8 million in 2023, then plunged by 76.89% to $5.5 million in 2024, then rose by 10.91% to $6.1 million in 2025, then fell by 8.2% to $5.6 million in 2026.
• Business Quant data shows AVNS's Non-Current Deferred Tax Liability at $5.6 million in Q1 2026, $6.1 million in Q4 2025, and $6.3 million in Q3 2025.